INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
BA

Brady James Aloysius

DirectorCIK 0001916987

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score13
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
BA
Brady James AloysiusDirector
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
24.2K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Xeris Biopharma Holdings, Inc.Director · Apr 1, 2026
8
BA
Brady James AloysiusDirector
XERSXeris Biopharma Holdings, Inc.
Grant or award
A
$203K
33.0K sh
Jun 4, 2026
Jun 5, 2026
traded Jun 4, 2026
+1d
SEC FORM 4

Evidence

12
BA
Brady James AloysiusDirector
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
10.8K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC FORM 4

Evidence